NextGen HRR Gene Panel

Also known as: NextGen : HRR Gene Panel - Somatic

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Report

Within 24 Hours

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

The NextGen HRR Gene Panel is a specialized genetic test that focuses on the evaluation of a set of 15 genes involved in the Homologous Recombination Repair (HRR) pathway. This panel aims to identify variations or mutations within genes such as ATM, BARD1, BRCA1, BRCA2, BRIP1, CDK12, CHEK1, CHEK2, FANCL, PALB2, PPP2R2A, RAD51B, RAD51C, RAD51D, and RAD54L. The analysis of these genes is crucial for assessing an individual's susceptibility to hereditary cancers and guiding personalized treatment and management strategies.

NextGen : HRR Gene Panel - Somatic Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the NextGen : HRR Gene Panel - Somatic with a clear pricing structure.

The NextGen : HRR Gene Panel - Somatic Price in Rajkot is ₹ 25,300 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

What does the NextGen HRR Gene Panel measure?

The NextGen HRR Gene Panel employs advanced sequencing techniques to analyze the DNA sequence of the 15 specified genes. It identifies variations, mutations, or pathogenic changes within these genes that could be linked to an increased risk of developing hereditary cancers.

Why is the NextGen HRR Gene Panel done?

• Hereditary Cancer Risk Assessment: The test is performed to assess an individual's genetic predisposition to hereditary cancers, especially those associated with mutations in the HRR pathway genes. • Personalized Treatment: Identification of pathogenic mutations helps tailor treatment approaches, such as targeted therapies or preventative measures. • Family Planning: Results can guide decisions about family planning and enable genetic counseling for at-risk individuals.

When is the NextGen HRR Gene Panel recommended and who should take the test?

The NextGen HRR Gene Panel is recommended for: • Individuals with a family history of hereditary cancers, especially breast, ovarian, prostate, and pancreatic cancers. • Those with personal or family history suggesting a potential HRR pathway gene mutation. • Individuals with cancer diagnoses at a young age or bilateral cancers.

What if the results of the NextGen HRR Gene Panel are abnormal?

Abnormal results may indicate the presence of pathogenic mutations in the HRR pathway genes, increasing the individual's risk of developing certain types of hereditary cancers. These results can guide medical decisions, surveillance, and counselling.

What to expect during the NextGen HRR Gene Panel?

The NextGen HRR Gene Panel requires a sample of tissue preserved in a formalin-fixed paraffin-embedded (FFPE) block. Advanced sequencing techniques are then applied to analyze the DNA extracted from the sample.

What preparations are required before the NextGen HRR Gene Panel?

Generally, there are no specific preparations required for this test. However, individuals might be advised to follow any instructions provided by their healthcare provider.

What other tests may be ordered with the NextGen HRR Gene Panel?

Depending on the results and suspected conditions, additional tests like imaging studies, targeted cancer screenings, or more comprehensive genetic analyses might be recommended to further refine the individual's risk profile.

What is the NextGen HRR Gene Panel also known as?

• Homologous Recombination Repair (HRR) Gene Analysis • Hereditary Cancer Risk Genetic Panel

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.